SPY330.06+1.27 0.39%
DIA268.41+1.69 0.63%
IXIC10,941.17+38.37 0.35%

UBS Maintains Buy on CVS Health, Raises Price Target to $78

UBS maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $71 to $78.

Benzinga · -

UBS maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $71 to $78.